Multiple P2Y receptors mediate contraction in guinea pig mesenteric vein

General Pharmacology

Volumn 34, Issue 2, 2000, Pages 127-136

  Mutafova Yambolieva, Violeta N ^a   Carolan, Bernadette M ^a   Harden, T Kendall ^b   Keef, Kathleen D ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Guinea pig mesenteric artery; Guinea pig mesenteric vein; P2 receptors

Indexed keywords

2 METHYLENE THIO ADENOSINE 5' DIPHOSPHATE; 2 METHYLENE THIO ADENOSINE 5' TRIPHOSPHATE; ADENINE DERIVATIVE; ADENOSINE 3',5' BIPHOSPHATE; ADENOSINE 5K' O (3 THIOTRIPHOSPHATE); ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA DEXTRO ADENOSINE 5' TRIPHOSPHATE; BETA,GAMMA LEVO ADENOSINE 5' TRIPHOSPHATE; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIMIDINE; SURAMIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIZATION; GUINEA PIG; MALE; MESENTERIC ARTERY; MESENTERIC VEIN; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VENOCONSTRICTION;

ADENINE NUCLEOTIDES; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; GUINEA PIGS; MALE; MESENTERIC ARTERY, INFERIOR; MESENTERIC VEINS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHLORIDE; PYRIDOXAL PHOSPHATE; PYRIMIDINE NUCLEOTIDES; RECEPTORS, PURINERGIC P2; SURAMIN; URIDINE TRIPHOSPHATE;

EID: 0033838533     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(00)00054-9     Document Type: Article

References (37)

1. Anderson C.M., Parkinson F.E. Potential signalling roles for UTP and UDP. sources, regulation and release of uracil nucleotides Trends Pharmac Sci. 18:1997;387-392.
2. Arunlakshana O., Schild H.O. Some quantitative studies of drug antagonists. Br J Pharmac Chemother. 14:1959;48-58.
3. Boarder M.R., Hourani S.M.O. The regulation of vascular function by P2 receptors. multiple sites and multiple receptors Trends Pharmac Sci. 19:1998;99-107.
4. Boyer J.L., Romero T., Schachter J.B., Harden T.K. Identification of competitive antagonists of the P2Y1 receptor. Mol Pharmac. 50:1996;1323-1329.
5. Brock J.A., Cunnane T.C. Electrophysiology of neuroeffector transmission in smooth muscle. Burnstock G., Hoyle C.H.V. Autonomic neuroeffector mechanisms. 1992;121-213 Harwood Academic Publishers, London.
6. Burnstock G. Co-transmission. the Fifth Heymens Memorial Lecture Arch Int Pharmacodyn Ther. 304:1990;7-33.
7. Burnstock G. Development and perspectives of the purinoceptor concept. J Auton Pharmac. 16:1996;295-302.
8. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmac. 16:1985;433-440.
9. Chen C.-C., Akopian A.N., Sivilotti L., Colquhoun D., Burnstock G., Wood J.N. A P2X purinoceptor expressed by a subset of sensory neurons. Nature. 377:1995;428-431.
10. Dillon P.F., Murphy R.A. High force development and crossbridge attachment in smooth muscle from swine carotid arteries. Circ Res. 50:1982;799-804.
11. Erlinge D., Hou M., Webb T.E., Barnard E.A., Möller S. Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun. 248:1998;864-870.
12. Evans R.J., Surprenant A., North R.A. P2X receptors. Cloned and native Turner J.T., Weisman G.A., Fedan J.S. The P2 nucleotide receptors. 1997;43-61 Humana Press, Totowa, NJ.
13. Fredholm B.B., Abbracchio M.P., Burnstock G., Dubyak G.R., Harden T.K., Jackobson K.A., Achwabe U., Williams M. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmac Sci. 18:1997;79-82.
14. Herlihy J.T., Murphy R.A. Length-tension relationship of smooth muscle of the hog carotid artery. Circ Res. 33:1973;275-283.
15. 2 purinoceptors in mesenteric arteries and veins of the guinea-pig. Br J Pharmac. 96:1989;993-999.
16. Hottenstein O.D., Kreulen D.L. Comparison of the frequency dependence of venous and arterial responses to sympathetic nerve stimulation in guinea-pigs. J Physiol (Lond). 384:1987;153-167.
17. Hourani S.M.O., Chown J.A. The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in guinea-pig urinary bladder. Gen Pharmac. 20:1989;413-416.
18. Kennedy C., Leff P. How should P2X purinoceptors be classified pharmacologically? Trends Pharmac Sci. 16:1995;168-174.
19. Kreulen D.L. Activation of mesenteric arteries and veins by preganglionic and postganglionic nerves. Am J Physiol. 251:1986;H1267-H1275.
20. Kullapuli S.P., Daniel J.L. P2 receptor subtypes in the cardiovascular system. Biochem J. 336:1998;513-523.
21. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature. 377:1995;432-435.
22. Miyagi Y., Kobayashi S., Nishimura J., Fukui M., Kanaide H. Dual regulation of cerebrovascular tone by UTP. P2U receptor-mediated contraction and endothelium-dependent relaxation Br J Pharmac. 118:1996;847-856.
23. North R.A., Barnard E.A. Nucleotide receptors. Curr Opin Neurobiol. 7:1997;346-357.
24. Ohara N., Konishi C., Naito Y. ATP-induced, P2U purinoceptor-mediated constriction of isolated, perfused mesenteric beds of the rat. Eur J Pharmac. 363:1998;157-160.
25. Palmer R.K., Boyer J.L., Schachter J.B., Nicholas R.A., Harden T.K. Agonist action of adenosine triphosphate as the human P2Y1 receptor. Mol Pharmac. 54:1998;1118-1123.
26. Rae M.G., Rowan E.G., Kennedy C. Pharmacological properties of P2X3-receptors present in neurones of the rat dorsal root ganglia. Br J Pharmac. 124:1998;176-180.
27. Rubino A., Burnstock G. Evidence for a P2-purinoceptor mediating vasoconstricton by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat. Br J Pharmac. 118:1996;1415-1420.
28. Satterwhite C.M., Farrelly A.M., Bradley M.E. Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells. Am J Physiol. 276(part 2):1999;H1091-H1097.
29. Schachter J.B., Li Q., Boyer J.L., Nicholas R.A., Harden T.K. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br J Pharmac. 118:1996;167-173.
30. Stjärne L., Åstrand P., Bao J.-X., Gonon F., Msghina M., Stjarne E. Spatiotemporal pattern of quantal release of ATP and noradrenaline from sympathetic nerves. consequences for neuromuscular transmission Stjärne L., Greengard P., Grillner S., Hökfelt T., Ottson D. Advances in second messenger and phosphoprotein research. molecular and cellular mechanisms of neurotransmitter release:1994;461-496 Raven, New York.
31. Suzuki H. Effects of endogenous and exogenous noradrenaline on the smooth muscle of guinea-pig mesenteric vein. J Physiol (Lond). 321:1981;495-512.
32. Trezise D.J., Michael A.D., Grachames C.B.A., Khakh B.S., Surprenant A., Humpherey P.P.A. The selective P2X purinoceptor agonist, β,γ-methylene-L-adenosine 5′-triphosphate, discriminates between smooth muscle and neuronal P2X receptors. Naunyn-Schmiedeberg's Arch Pharmac. 351:1995;603-609.
33. Valera S., Hussy N., Evans R.J., Adami N., North R.A., Surprenant A., Buell G.N. A new class of ligand-gated ion channel defined by P2X purinoceptor for extracellular ATP. Nature. 371:1994;516-519.
34. Vigne P., Pacaud P., Urbach V., Feolde E., Breittmayer J.P., Frelin C. The effect of PPADS as an antagonist of inositol (1,4,5)triphosphate induced intracellular calcium mobilization. Br J Pharmac. 119:1996;360-364.
35. Von Kügelgen I., Krumme B., Schaible U., Scholler-Meyer P.J., Rump L.C. Vasoconstrictor responses to the P2X purinoceptor agonist, β,γ-methylene-L-ATP in human cutaneous and renal blood vessels. Br J Pharmac. 116:1995;1932-1936.
36. Vulchanova L., Arvidsson U., Riedl M., Wang J., Buell G., Surprenant A., North R.A., Elde R. Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci USA. 93:1996;8063-8067.
37. Ziganshin A.U., Ziganshina L.E., King B.F., Burnstock G. Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pfluegers Arch. 429:1995;412-418.